David Chu

3.8k citations

85 papers · 2.0k indexed · 1 hit paper · h-index 23

Impact in

Ophthalmology top 0.5%
- Ocular Diseases and Behçet’s Syndrome
- Retinal and Optic Conditions
- Ocular Infections and Treatments
- Retinal Diseases and Treatments
Rheumatology top 2%
- Systemic Lupus Erythematosus Research

Papers in ⓘ

Ophthalmology 51
- Ocular Diseases and Behçet’s Syndrome 31
- Ocular Infections and Treatments 15
- Retinal and Optic Conditions 14
- Intraocular Surgery and Lenses 11
Radiology, Nuclear Medicine and Imaging 24
- Corneal Surgery and Treatments 13
- Corneal surgery and disorders 12

Co-authors: C. Stephen Foster (10 shared papers)George N. Papaliodis (2 shared papers)Quan Dong Nguyen (4 shared papers)Anton M. Kolomeyer (17 shared papers)Anne Camez (1 shared paper)Philippe Kestelyn (1 shared paper)Arnd Heiligenhaus (1 shared paper)Jennifer E. Thorne (2 shared papers)
Journals: Ocular Immunology and Inflammation (8 papers)Eye & Contact Lens Science & Clinical Practice (5 papers)Cornea (4 papers)Journal of Cataract & Refractive Surgery (3 papers)Journal of Ocular Pharmacology and Therapeutics (3 papers)
Partner nations: United States United Kingdom Israel

In The Last Decade

David Chu

81 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Adalimumab in Patients with Active Noninfectious Uveitis 2016 · 418 citations

Peers

Countries citing papers authored by David Chu

Since Specialization

Citations

This map shows the geographic impact of David Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chu more than expected).

Fields of papers citing papers by David Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chu. The network helps show where David Chu may publish in the future.

Co-authors

The 25 scholars most cited alongside David Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Chu Line = papers co-authored together David Chu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adalimumab in Patients with Active Noninfectious Uveitis New England Journal of Medicine ·Glenn J. Jaffe, Andrew D. Dick, Antoine P. Brézin, Quan Dong Nguyen, Jennifer E. Thorne, Philippe Kestelyn, Talin Barisani‐Asenbauer, Pablo Franco, Arnd Heiligenhaus, David K. Scales, David Chu, Anne Camez, Nisha V. Kwatra, Alexandra Song, Martina Kron, Samir Tari, Eric B. Suhler Hit paper breakdown →	2016	418
2	Supplementary Materials for Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus P. Dryja, A. Wright, Gerard Bruin, Christian Antoni, Michael H. Gold, Patrick Durez, Paul P. Tak, Juan J. Go, C. Stephen Foster, Rosa Y. Kim, C. Michael Samson, Naomi S. Falk, David Chu, David Callanan, Asifa Haider	2010	139
3	The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management Survey of Ophthalmology ·C. Stephen Foster, Srishti Kothari, Stephen D. Anesi, Albert T. Vitale, David Chu, Jamie Lynne Metzinger, Olga Cerón	2015	123
4	Retrospective Case Review of Pediatric Patients with Uveitis Treated with Infliximab Ophthalmology ·Rajmohan Rajaraman, Yasutoshi Kimura, Shifang Li, Keith Haines, David Chu	2006	113
5	Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis American Journal of Ophthalmology ·Yasir J. Sepah, Mohammad Ali Sadiq, David Chu, Mark Dacey, Ron P. Gallemore, Pouya N. Dayani, Mostafa Hanout, Muhammad Hassan, Rubbia Afridi, Aniruddha Agarwal, Muhammad Sohail Halim, V. Diana, Quan Dong Nguyen	2017	103
6	Elevated Levels of Interleukin 6 in the Vitreous Fluid of Patients with Pars Planitis and Posterior Uveitis: The Massachusetts Eye & Ear Experience and Review of Previous Studies Ocular Immunology and Inflammation ·Víctor Pérez, George N. Papaliodis, David Chu, Fahd Anzaar, William G. Christen, C. Stephen Foster	2004	80
7	Complications in resident-performed phacoemulsification cataract surgery at New Jersey Medical School British Journal of Ophthalmology ·Neelakshi Bhagat, N.J. Nissirios, Lindsay Potdevin, Jaeho Chung, Pierre Louis Lama, Marco A. Zarbin, R. Fechtner, Suqin Guo, David Chu, Paul D. Langer	2007	79
8	Treatment of ocular inflammatory disorders with daclizumab Ophthalmology ·George N. Papaliodis, David Chu, C. Stephen Foster	2003	74
9	Molecular characterization, biofilm analysis and experimental biofouling study of Fusariumisolates from recent cases of fungal keratitis in New York State BMC Ophthalmology ·Madhu Dyavaiah, Rama Ramani, David Chu, David C. Ritterband, Mahendra Shah, William A. Samsonoff, Sudha Chaturvedi, Vishnu Chaturvedi	2007	50
10	An Outbreak of Fusarium Keratitis Associated With Contact Lens Use in the Northeastern United States Cornea ·J.J. Gorscak, Brandon D. Ayres, Neelakshi Bhagat, K.M. Hammersmith, Christopher J. Rapuano, Elisabeth J. Cohen, Michele Burday, Neena Mirani, Donald Jungkind, David Chu	2007	49
11	Ocular manifestations and concepts of systemic vasculitides Survey of Ophthalmology ·Victor L. Perez, Sai H. Chavala, M. Ahmed, David Chu, Panos Zafirakis, Stefanos Baltatzis, Vicente Ocampo, C. Stephen Foster	2004	43
12	Reorganization of the Hand Somatosensory Cortex Following Perinatal Unilateral Brain Injury Neuropediatrics ·David Chu, Peter R. Huttenlocher, David Levin, Vernon L. Towle	2000	40
13	Noninvasive identification of human central sulcus: a comparison of gyral morphology, functional MRI, dipole localization, and direct cortical mapping NeuroImage ·Vernon L. Towle, Leila Khorasani, S. J. Uftring, Charles Pelizzari, Robert K. Erickson, Jean‐Paul Spire, K Hoffmann, David Chu, Michael Scherg	2003	39
14	Paraproteinemic Keratopathy Ophthalmology ·Tatyana Milman, Andrew Kao, David Chu, Matthew Gorski, Annie Steiner, Carrie Zaslow Simon, Carolyn Shih, Anthony J. Aldave, Ralph C. Eagle, Frederick A. Jakobiec, Ira J. Udell	2015	38
15	Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA Journal of Ophthalmic Inflammation and Infection ·David Chu, Scott J. Johnson, Usha G. Mallya, Matthew Davis, Rachael Sorg, M.S. Duh	2013	33
16	Sympathetic Ophthalmia International Ophthalmology Clinics ·David Chu, C. Stephen Foster	2002	32
17	The mechanical state of intracranial tissues in elderly subjects studied by imaging CSF and brain pulsations Magnetic Resonance Imaging ·S. J. Uftring, David Chu, Noam Alperin, David Levin	2000	31
18	Lirentelimab for severe and chronic forms of allergic conjunctivitis Journal of Allergy and Clinical Immunology ·Stephen D. Anesi, Joseph Tauber, Quan Dong Nguyen, Peter Y. Chang, Gregg J. Berdy, Charles C. Lin, David Chu, H. Terry Levine, Andrew Fernandez, Neeta S. Roy, Penny A. Asbell, Andrea Kantor, Alan T. Chang, Bhupinder Singh, Bradford A. Youngblood, Bennie H. Jeng, Vishal Jhanji, Henrik Rasmussen, C. Stephen Foster	2022	28
19	INFECTIOUS KERATITIS–ASSOCIATED ENDOPHTHALMITIS Retina ·Mehrdad Malihi, Xintong Li, Shriji Patel, Thomas Eck, David Chu, Marco A. Zarbin, Neelakshi Bhagat	2016	27
20	The Blood Oxygen Level–Dependent Functional MR Imaging Signal Can Be Used to Identify Brain Tumors and Distinguish Them from Normal Tissue American Journal of Neuroradiology ·S. Feldman, David Chu, Michael Schulder, Michael A. Barry, E.-S. Cho, Wen-Ching Liu	2009	25

About David Chu

David Chu is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Rheumatology, Public Health, Environmental and Occupational Health and Immunology and Allergy, having authored 85 papers that have together received 2.0k indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (31 papers), Ocular Surface and Contact Lens (21 papers), Ocular Infections and Treatments (15 papers), Retinal and Optic Conditions (14 papers), Corneal Surgery and Treatments (13 papers), Corneal surgery and disorders (12 papers), Intraocular Surgery and Lenses (11 papers) and Systemic Lupus Erythematosus Research (9 papers). The work is most often cited by research in Ophthalmology (1.4k citations), Rheumatology (557 citations), Hematology (210 citations), Radiology, Nuclear Medicine and Imaging (317 citations) and Immunology (210 citations). David Chu has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include C. Stephen Foster, George N. Papaliodis, Quan Dong Nguyen, Anton M. Kolomeyer, Anne Camez, Philippe Kestelyn, Arnd Heiligenhaus, Jennifer E. Thorne, Antoine P. Brézin and Samir Tari. Their work appears in journals such as Ocular Immunology and Inflammation, Eye & Contact Lens Science & Clinical Practice, Cornea, Journal of Cataract & Refractive Surgery and Journal of Ocular Pharmacology and Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact